At a glance
The FY26 Peer Reviewed Medical Research Program Research Advancement Award supports basic research on a congressionally directed topic area that is directly relevant to military health and tied to one of the program’s strategic goals. Applicants must include preliminary data, and the award is not intended for translational research. U.S. Department of War organizations may apply, including foreign and domestic, for-profit and nonprofit, and public or private entities; awards are made to organizations, not individuals. The program expects about $19.6 million to fund about 14 awards, with a total cost cap of $1.4 million per award and a performance period of up to 4 years. Cost sharing is not required, and applications must fit one FY26 PRMRP topic area and strategic goal or may be administratively withdrawn.
What it funds
Official description from grants.gov
Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Research Advancement Award supports fundamental research studies that will make an important contribution towards research, patient care, and/or quality of life for a disease or condition related to one of the congressionally directed FY26 PRMRP topic areas and one of the FY26 PRMRP portfolio-specific strategic goals. Distinctive Features: Applications must include preliminary data. The Research Advancement Award supports use-inspired basic research to further or validate preliminary findings for short- and long-term impact. Proposed research projects may range from hypothesis testing to expansion of mature data. Funding Details: The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $19.6M to fund approximately 14 Research Advancement Award applications with total cost caps of $1.4M per award. The maximum period of performance is 4 years. It is anticipated that awards made from this FY26 funding opportunity will be funded with FY26 funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027.
Who can apply
- Unrestricted